GW PHARMA LIMITED
Patent Owner
Stats
- 42 US PATENTS IN FORCE
- 22 US APPLICATIONS PENDING
- Feb 20, 2018 most recent publication
Details
- 42 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 4,947 Total Citation Count
- Apr 05, 2001 Earliest Filing
- 29 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0290,869 EXTRACTION OF PHARMACEUTICALLY ACTIVE COMPONENTS FROM PLANT MATERIALSMar 23, 17Oct 12, 17[A61K, B01D]
2017/0273,913 USE OF ONE OR A COMBINATION OF PHYTO-CANNABINOIDS IN THE TREATMENT OF EPILEPSYNov 09, 16Sep 28, 17[A61K]
2017/0079,933 COMPOSITIONS COMPRISING CANNABINOIDS FOR TREATMENT OF NAUSEA, VOMITING, EMESIS, MOTION SICKNESS OR LIKE CONDITIONSSep 28, 16Mar 23, 17[A61K]
2016/0360,721 CANNABIS SATIVA PLANTS RICH IN CANNABICHROMENE AND ITS ACID, EXTRACTS THEREOF AND METHODS OF OBTAINING EXTRACTS THEREFROMMay 13, 16Dec 15, 16[A61K, A01H, A01G]
2016/0361,290 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISEASE AND/OR SYMPTOMS IN ARTHRITISMar 14, 16Dec 15, 16[A61K]
2016/0243,075 TETRAHYDROCANNABIVARIN (THC) FOR USE IN THE PROTECTION OF PANCREATIC ISLET CELLSMay 16, 14Aug 25, 16[A61K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9675579 Tetrahydrocannabivarin for use in the treatment of nausea and vomitingApr 14, 14Jun 13, 17[A61K]
9522123 Use of one or a combination of phyto-cannabinoids in the treatment of epilepsyDec 22, 14Dec 20, 16[A61K]
9421187 Phytocannabinoids for use in the treatment of intestinal inflammatory diseasesNov 21, 12Aug 23, 16[A61K]
9205063 Cannabinoid-containing plant extracts as neuroprotective agentsJan 24, 14Dec 08, 15[A61K, A01N]
9125859 Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsyMar 30, 11Sep 08, 15[A61K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0136,127 USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR INCREASING RADIOSENSITVITY IN THE TREATMENT OF A BRAIN TUMOURAbandonedJun 19, 14May 19, 16[A61K]
2014/0221,469 PHYTOCANNABINOIDS FOR USE IN THE TREATMENT OF CANCERAbandonedSep 10, 12Aug 07, 14[A61K]
2012/0059,062 COMPOSITIONS COMPRISING CANNABINOIDS FOR TREATMENT OF NAUSEA, VOMITING, EMESIS, MOTION SICKNESS OR LIKE CONDITIONSAbandonedAug 31, 11Mar 08, 12[A61K, C07C, A61P]
2011/0098,348 CANNABIS SATIVA PLANTS RICH IN CANNABICHROMENE AND ITS ACID, EXTRACTS THEREOF AND METHODS OF OBTAINING EXTRACTS THEREFROMAbandonedApr 09, 09Apr 28, 11[A61K, A01H, A01G]
2011/0086,113 CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS (E.G. SERM OR ALKYLATING AGENTS)AbandonedJun 04, 09Apr 14, 11[A61K, A61P]
2010/0317,729 NEW PHARMACEUTICAL FORMULATION COMPRISING CANNABIDIOL AND TETRAHYDROCANNABIDIVARINAbandonedJul 04, 08Dec 16, 10[A61K, A61P]
2010/0286,098 USE OF TETRAHYDROCANNABINOL AND/OR CANNABIDIOL FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASEAbandonedJun 25, 08Nov 11, 10[A61K, A61P]
2010/0035,978 COMBINATION OF CANNABINOIDS FOR THE TREATMENT OF PERIPHERAL NEUROPATHIC PAINAbandonedOct 31, 06Feb 11, 10[A61K, A61P]
2010/0016,418 Cannabinoids for use in the treatment of neuropathic painAbandonedJun 21, 07Jan 21, 10[A61K]
2009/0197,941 Pharmaceutical Compositons for the Treatment of Chronic Obstructive Pulmonary DiseaseAbandonedOct 11, 06Aug 06, 09[A61K, A61P]
2008/0167,483 EXTRACTION OF PHARMACEUTICALLY ACTIVE COMPONENTS FROM PLANT MATERIALSAbandonedMar 17, 08Jul 10, 08[C07D]
2008/0139,667 Pharmaceutical Compositions For the Treatment of Disease and/or Symptoms in ArthritisAbandonedJun 07, 05Jun 12, 08[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.